Acquired hepatocerebral degeneration
Authors:
- 17 February 2009
- journal article
- case report
- Published by Springer Nature in Journal of Neurology
- Vol. 256 (3) , 320-332
Abstract
Cirrhosis and its co-morbidities may cause a variety of neurological complications, the most common being bouts of toxic metabolic encephalopathy. A proportion of patients with chronic liver disease develop acquired hepatocerebral degeneration (AHD), a chronic progressive neurological syndrome characterized by parkinsonism, ataxia and other movement disorders. This article reviews the clinical spectrum, pathophysiology, neuroimaging features and differential diagnosis of AHD along with emerging treatment options.Keywords
This publication has 159 references indexed in Scilit:
- Manganese accumulates primarily in nuclei of cultured brain cellsNeuroToxicology, 2008
- Case of Pediatric Acquired Chronic Hepatocerebral DegenerationPediatric Neurology, 2008
- Manganese: Recent advances in understanding its transport and neurotoxicityToxicology and Applied Pharmacology, 2007
- Manganese neurotoxicity: A focus on the neonatePharmacology & Therapeutics, 2007
- Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatmentNeuroscience Letters, 2006
- Clinical significance of extrapyramidal signs in patients with cirrhosisJournal of Hepatology, 2005
- Liver transplantation improves hepatic myelopathy: Evidence by three casesGastroenterology, 2003
- Orofacial dyskinesias in a patient with primary biliary cirrhosis: A clinicopathological case report and reviewMovement Disorders, 2002
- Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver diseaseHepatology, 1997
- Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluationMetabolic Brain Disease, 1995